# COVID-19 Novel Molecular Point of Care Diagnostics Evaluation

> **NCT06055218** · — · COMPLETED · sponsor: **Foundation for Innovative New Diagnostics, Switzerland** · enrollment: 600 (actual)

## Conditions studied

- COVID-19 Respiratory Infection

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06055218
- **Lead sponsor:** Foundation for Innovative New Diagnostics, Switzerland
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2023-01-30
- **Primary completion:** 2023-04-11
- **Final completion:** 2023-08-30
- **Target enrollment:** 600 (ACTUAL)
- **Last updated:** 2023-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06055218

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06055218, "COVID-19 Novel Molecular Point of Care Diagnostics Evaluation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06055218. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*